Biotech Values

[Jonathan Robinson]

I am not sure lost "prospects" of 5 percent has the same zing as lost actual biz of 5 percent especially given the long timeframe and therefore low odds of approval. This is not actual biz being lost just an opportunity lost, which has a different standard, ESP since it could be grouped as part of potential new products bucket with all the other applications.

Jon